The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Division of Nephrology, Rhode Island Hospital, Providence, RI, USA.
J Clin Hypertens (Greenwich). 2020 Nov;22(11):1960-1967. doi: 10.1111/jch.14051. Epub 2020 Sep 28.
Pulse pressure naturally increases over time as individuals' age due to arteriosclerosis and diffuse vascular stiffening. However, the differential for widened pulse pressure is broad and includes causes of hyperdynamic circulation and high-output heart failure, such as aortic regurgitation and hyperthyroidism. In the absence of an underlying cause, wide pulse pressure is a sign of deteriorating cardiovascular health and carries increased risk for mortality, disease progression, and adverse clinical outcomes in chronic diseases including cardiovascular disease and chronic kidney disease. Current emphasis of antihypertensive treatment on systolic and diastolic blood pressure does not always address pulse pressure, thus subjecting many patients to an independent risk factor for poor outcomes. Pulse pressure control is more successfully achieved with thiazide diuretics and long-acting nitrates when compared to other antihypertensive agents, but further research is needed to quantify the additional benefits of pulse pressure control over conventional blood pressure therapy. This case review provides an overview of the pathogenesis, pathologic causes, and treatment of widened pulse pressure and evaluates current evidence for pulse pressure as a predictor of clinical outcomes.
由于动脉硬化和弥漫性血管僵硬,脉搏压会随着个体年龄的增长而自然增加。然而,脉搏压增宽的鉴别诊断范围很广,包括高动力循环和高输出量心力衰竭的原因,如主动脉瓣反流和甲状腺功能亢进。在没有潜在病因的情况下,宽脉冲压是心血管健康恶化的标志,并增加了包括心血管疾病和慢性肾脏病在内的慢性疾病的死亡率、疾病进展和不良临床结局的风险。目前,抗高血压治疗对收缩压和舒张压的重视并不总是针对脉搏压,因此许多患者面临不良结局的独立风险因素。与其他降压药物相比,噻嗪类利尿剂和长效硝酸盐更能成功地控制脉搏压,但需要进一步研究来量化脉搏压控制相对于传统血压治疗的额外益处。本病例复习概述了脉搏压增宽的发病机制、病理原因和治疗,并评估了脉搏压作为临床结局预测因子的现有证据。